Nextvisit AI

Cover Block

PUBLIC

Attribute	Value
Name	Nextvisit AI
Tagline	AI-powered clinical documentation for behavioral health
Headquarters	Amityville, NY, USA
Founded	2021
Stage	Pre-Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Pre-seed
Total Disclosed	~$200,000 [PitchBook, 2025]

Links

PUBLIC

• Website: https://nextvisit.ai/
• LinkedIn: https://www.linkedin.com/company/nextvisit-inc
• Press Room: https://news.nextvisit.ai/

Executive Summary

PUBLIC

Nextvisit AI is a pre-seed venture developing an AI-powered clinical documentation platform built specifically for behavioral health providers, a wedge into a sector burdened by administrative burnout and a market that has yet to consolidate around a clear software leader [Nextvisit.ai, 2025]. Founded in 2021, the company was started by a practicing psychiatrist, Dr. Faisal Rafiq, and a software engineer, Ryan Yannelli, a pairing that grounds its product development in clinical workflows and technical execution [Doximity, 2026] [Ryan Yannelli, 2026]. Its core product is a passive AI scribe that transcribes patient sessions in real-time to generate structured clinical notes, aiming to eliminate dictation and manual data entry for therapists and psychiatrists [Asbury Park Press, 2026].

The company's early commercial traction, reported at $9,000 in monthly recurring revenue from 68 paying customers following a summer 2024 launch, provides a preliminary signal of product-market fit, though the scale remains extremely early [LinkedIn, 2025]. It has secured approximately $200,000 in pre-seed capital from the LAUNCH Fund and I2BF Global Ventures, and completed the associated LAUNCH Accelerator program, which provides initial validation and network access [PitchBook, 2025]. Over the next 12-18 months, the critical watchpoints will be the company's ability to convert its claimed base of 1,000+ health organizations into paying revenue, demonstrate scalable customer acquisition beyond early adopters, and navigate the complex integration and compliance requirements of the behavioral health IT landscape.

Data Accuracy: YELLOW -- Core product claims and team backgrounds are confirmed; early traction metrics are sourced from a single company post.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Pre-seed (total disclosed ~$200,000)

Company Overview

PUBLIC

Nextvisit AI was founded in 2021 by a practicing psychiatrist and a software engineer to address the specific documentation burden in behavioral health. The company is headquartered in Amityville, New York [Crunchbase]. The founding team, Dr. Faisal Rafiq and Ryan Yannelli, combined clinical experience with technical expertise to build a product focused on passive, real-time note capture for therapists and psychiatrists [Nextvisit.ai, 2025].

Key operational milestones follow a typical early-stage trajectory. The company graduated from Jason Calacanis's LAUNCH Accelerator program, an event noted in a press release in late 2025 [Access Newswire, November 2025]. In 2026, the company joined Intercom's startup program to augment its customer support capabilities [Nextvisit Press Room, May 2025]. Public traction metrics, posted on LinkedIn, indicate the company reached $9,000 in monthly recurring revenue with 68 paying customers shortly after its commercial launch [LinkedIn, 2025].

Data Accuracy: YELLOW -- Core facts (founding year, HQ, accelerator participation) are confirmed by multiple public sources. The $9,000 MRR figure is sourced solely from a company LinkedIn post.

Product and Technology

MIXED

The core proposition is a passive AI scribe designed to integrate into the natural flow of a behavioral health session. Nextvisit AI's platform uses real-time AI transcription to generate clinical notes, intake documentation, and SOAP notes from patient conversations, explicitly marketed as requiring "no dictation, no extra steps" [Nextvisit.ai, 2025]. The company's public messaging consistently frames this as a tool to reduce administrative burden and reclaim time for patient care [Asbury Park Press, 2026].

Product differentiation is anchored on specialization for behavioral health, a nuance the founders emphasize. A 2026 article by co-founder Ryan Yannelli outlines six evaluation factors for providers, highlighting the need for an AI scribe to understand longitudinal psychiatric histories and complex timelines, which are less relevant in general medical practice [Asbury Park Press, 2026]. The platform includes personalized templates and secure data management features, though specific technical details on security certifications or EHR integration partners are not publicly disclosed [Nextvisit.ai About].

• Technology stack. The underlying architecture is not detailed in public materials. The requirement for real-time, accurate transcription in a clinical setting suggests a reliance on speech-to-text models and a natural language processing layer trained on behavioral health terminology. This is inferred from the product's stated function; no job postings or technical blogs were available to confirm stack choices.
• Deployment model. The product is offered as a SaaS platform. The company joined Intercom's startup program in May 2025, indicating a focus on embedding customer support and communication tools within its service [Nextvisit Press Room, May 2025].

Data Accuracy: YELLOW -- Core product claims are confirmed by company website and press coverage, but technical specifications and integration details are not publicly available.

Market Research

PUBLIC The market for AI-powered clinical documentation is expanding under pressure from provider burnout and administrative inefficiency, but the behavioral health segment presents a distinct set of challenges and opportunities.

Third-party market sizing specific to AI scribes for behavioral health is not publicly available. For context, the broader AI in healthcare market is projected to reach $45.2 billion by 2026, according to a 2023 report from MarketsandMarkets [MarketsandMarkets, 2023]. The clinical documentation segment within that is a primary growth driver, though the behavioral health carve-out remains a niche. A more direct analog is the general behavioral health software market, which Grand View Research valued at $3.4 billion in 2022 and forecast to grow at a compound annual rate of 16.5% through 2030 [Grand View Research, 2023]. This suggests a substantial, growing addressable market for technology solutions, though Nextvisit's specific wedge is a fraction of this total.

Demand drivers are well-documented across industry research. The administrative burden on clinicians is a primary catalyst, with studies indicating physicians spend nearly two hours on administrative tasks for every one hour of patient care [Annals of Internal Medicine, 2016]. In behavioral health, this burden is compounded by the narrative-heavy nature of progress notes and the critical importance of longitudinal patient history. A 2026 article by the company's co-founder explicitly cites rising costs, failing reimbursements, and overwhelming paperwork as key pressures pushing providers toward automation [Asbury Park Press, 2026]. The tailwind of AI model improvements, particularly in speech recognition and natural language understanding for medical contexts, is enabling more accurate passive capture, which is a prerequisite for adoption in sensitive therapeutic settings.

Key adjacent markets include general medical AI scribes (e.g., for primary care or specialties like orthopedics) and broader electronic health record (EHR) systems. These represent both potential expansion corridors and competitive substitutes. A behavioral health provider might consider a generic medical scribe if it is sufficiently accurate, or may rely on templated note-taking within their existing EHR. The regulatory landscape adds complexity. Solutions must comply with HIPAA for data security and the HITECH Act for electronic health information exchange. Furthermore, documentation standards are dictated by payer requirements (Medicare, Medicaid, private insurers) and accreditation bodies, making template accuracy and compliance a non-negotiable feature for any clinical documentation tool.

Data Accuracy: YELLOW -- Market sizing is based on analogous, broader sector reports. Demand drivers are corroborated by independent medical journals and company commentary.

Competitive Landscape

MIXED

Nextvisit AI enters a crowded field of AI documentation tools by narrowing its focus exclusively to behavioral health, a segment where generic medical scribes often fall short on clinical nuance. The competitive map is shaped by three distinct layers: established EHR giants with embedded scribe features, horizontal AI documentation startups, and a small but growing set of purpose-built behavioral health solutions.

• EHR and practice management incumbents. Companies like Epic, Cerner, and Athenahealth offer dictation and basic note-capture tools, but their AI capabilities are often generic and not tailored to the longitudinal, narrative-heavy documentation of psychiatry and therapy. Their primary advantage is deep integration within the existing clinical workflow, making displacement difficult.
• Horizontal AI medical scribes. Startups such as Nabla, Suki, and DeepScribe target a broad range of medical specialties with ambient listening technology. They compete on technical accuracy and breadth of specialty coverage, but their models may not be trained on the specific language patterns, assessment scales, and treatment plans central to behavioral health [Asbury Park Press, 2026].
• Behavioral health-specific tools. This is Nextvisit's direct competitive arena, though no named, funded pure-play competitors were identified in public sources. The space includes features within broader behavioral health EHRs like Valant and SimplePractice, which may be adding AI note generation, and potential new entrants attracted by the same market wedge.

The company's current defensible edge rests almost entirely on founder domain expertise and a focused product thesis. Dr. Faisal Rafiq's 15 years as a practicing psychiatrist provides an inherent understanding of the documentation pain points and regulatory requirements specific to the field [Doximity, 2026]. This translates into product decisions around capturing nuanced patient histories and tracking longitudinal timelines, which a generic model might miss. However, this edge is perishable; it is a product-design and training-data advantage that can be replicated by larger horizontal players who choose to invest in building a behavioral health-specific model or by acquiring clinical expertise.

Nextvisit is most exposed on two fronts: distribution and capital. It lacks the deep EHR integrations that are often a prerequisite for adoption at large health systems, a channel dominated by the incumbent EHR vendors and their partners. Furthermore, with a disclosed $200,000 in pre-seed capital [PitchBook, 2025], its resources are minimal compared to well-funded horizontal AI scribe companies that have raised tens or hundreds of millions of dollars. This limits its ability to outspend competitors on sales, marketing, and model training, creating a vulnerability to being out-executed or out-innovated by better-capitalized rivals.

The most plausible 18-month scenario involves continued fragmentation. A winner emerges if a company can secure a strategic partnership with a major behavioral health EHR platform, embedding its AI scribe directly into the dominant workflow. A loser scenario materializes if horizontal AI scribe companies successfully launch robust behavioral health modules, leveraging their superior capital and existing sales footprints to capture the segment before focused players like Nextvisit can achieve critical mass. For Nextvisit, the path likely depends on proving that its deep vertical focus translates to meaningfully better clinical outcomes and user adoption, metrics that could attract the partnership or funding needed to scale.

Data Accuracy: YELLOW -- Competitive analysis is inferred from product positioning and market structure; no direct competitor financials or launch dates are publicly confirmed for the behavioral health AI scribe niche.

Opportunity

PUBLIC The opportunity for Nextvisit AI is to become the default clinical documentation layer for the fragmented, underserved, and high-burnout behavioral health sector, a wedge that could unlock a platform position in a market where administrative burden is a primary constraint on practice economics and provider supply.

The headline opportunity is to establish the category-defining AI scribe for behavioral health, a specialized niche that generic medical transcription services often underserve. The company's positioning as "built exclusively for behavioral health" [Asbury Park Press, 2026] and its founding by a practicing psychiatrist [Nextvisit Press Room, 2025] provide a specific wedge into a market where clinical nuance,longitudinal psychiatric histories, therapy session dynamics, and specific billing codes,creates a defensible product moat. This outcome is reachable because the core pain point is acute and well-documented: provider burnout driven by administrative paperwork is a systemic issue in mental healthcare [Nextvisit AI, 2026]. A solution that demonstrably returns time to patient care, as the company claims its product does [Asbury Park Press, 2026], addresses a non-discretionary need for efficiency, making adoption a matter of clinical and financial survival rather than optional technology upgrade.

Growth scenarios outline concrete paths from early traction to scaled platform. The company's cited post-launch milestone of 68 paying customers [LinkedIn, 2025] provides a beachhead for the following expansion plays.

Scenario	What happens	Catalyst	Why it's plausible
Specialized Group Practice Adoption	Nextvisit becomes the standard documentation tool for mid-sized behavioral health group practices (10-50 providers).	A referenceable deployment with a multi-location practice demonstrates ROI and workflow integration.	The product is already marketed directly to behavioral health organizations [Nextvisit.ai, 2025]. Early traction with 68 customers suggests initial product-market fit within the target demographic.
EHR-Agnostic Integration Partner	The company achieves formal partnerships with major EHR vendors serving behavioral health, becoming a recommended or embedded scribe solution.	A co-marketing or technical integration agreement with a platform like Athenahealth or a specialized behavioral health EHR.	The company's graduation from the LAUNCH Accelerator [Access Newswire, 2025] provides network access to potential enterprise partners. The focus on secure, API-driven data management [Nextvisit.ai About] aligns with integration requirements.

What compounding looks like centers on a data and workflow flywheel. Each new behavioral health provider that adopts the system contributes session data that, when anonymized and aggregated, can improve the AI's accuracy for psychiatric terminology, therapy modalities, and documentation templates specific to the field. This creates a product improvement loop that generic scribes cannot easily replicate. Furthermore, within group practices or health systems, adoption by one clinician can drive peer-to-peer referrals, leveraging the inherent network effects of shared administrative protocols and billing practices. The company's early move to join Intercom's startup program to scale support capabilities [Nextvisit Press Room, May 2025] is a cited signal of preparing for this kind of user-driven growth.

The size of the win can be framed by looking at comparable outcomes in adjacent healthtech SaaS. Companies like Notable Health (AI-powered clinical documentation) and Augmedix (AI medical scribe) have achieved valuations in the hundreds of millions of dollars based on enterprise contracts and scaling revenue. While direct public comparables for a pure-play behavioral health scribe are scarce, the valuation framework for vertical SaaS in healthcare often applies revenue multiples of 8x-15x for growing, capital-efficient models. If the "Specialized Group Practice Adoption" scenario plays out and Nextvisit captures a low-single-digit percentage of the U.S. behavioral health provider market, translating to thousands of subscribing clinicians, the company's valuation could reach the low hundreds of millions of dollars (scenario, not a forecast). This outcome hinges on translating early niche traction into durable, expanding contracts with the organizational buyers that control provider workflows.

Data Accuracy: YELLOW -- Growth scenarios are extrapolated from cited product positioning and early traction metrics; the size of the win is inferred from adjacent market comparables rather than direct financial projections.

Sources

PUBLIC

1. [PitchBook, 2025] Nextvisit AI 2025 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/567518-50

2. [Nextvisit.ai, 2025] Nextvisit AI Medical Scribe | https://nextvisit.ai/

3. [Doximity, 2026] Dr. Faisal Rafiq, MD - Amityville, NY | Psychiatry on Doximity | https://www.doximity.com/pub/faisal-rafiq-md

4. [Ryan Yannelli, 2026] Ryan Yannelli | Technologist, Founder, Advocate | https://ryanyannelli.com/

5. [Asbury Park Press, 2026] Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026 | https://www.app.com/press-release/story/17446/nextvisit-co-founder-ryan-yannelli-identifies-six-critical-factors-for-behavioral-health-providers-evaluating-ai-scribes-in-2026/

6. [LinkedIn, 2025] Nextvisit Inc | LinkedIn | https://www.linkedin.com/company/nextvisit-inc

7. [Crunchbase] Nextvisit AI - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/nextvisit

8. [Access Newswire, November 2025] Nextvisit AI Graduates from Jason Calacanis’ LAUNCH Accelerator | https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/nextvisit-ai-graduates-from-jason-calacanis-launch-accelerator-advanc-1119859

9. [Nextvisit Press Room, May 2025] Nextvisit AI Joins Intercom Startup Program | https://news.nextvisit.ai/91082-nextvisit-ai-joins-intercom-startup-program-accelerates-support-capabilities-to-meet-growing-demand-in-behavioral-health-tech

10. [Nextvisit.ai About] About Us & Our Mission | Nextvisit AI | https://nextvisit.ai/about-us

11. [MarketsandMarkets, 2023] AI in Healthcare Market | https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

12. [Grand View Research, 2023] Behavioral Health Software Market Size Report, 2022-2030 | https://www.grandviewresearch.com/industry-analysis/behavioral-health-software-market

13. [Annals of Internal Medicine, 2016] Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties | https://www.acpjournals.org/doi/10.7326/M16-0961

14. [Nextvisit AI, 2026] Reducing Provider Burnout | Nextvisit AI | https://get.nextvisit.ai/about-us